Belite Bio (BLTE) Tops Q3 EPS by 22c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Wolfe Research Starts Federal Realty Investment Trust (FRT) at Outperform
• Chevron (CVX) call put ratio 2.8 calls to 1 put as WTI Crude oil trades above $74
• BofA Securities Downgrades Truist Financial (TFC) to Neutral